| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845691 | Pulmonary Pharmacology & Therapeutics | 2015 | 7 Pages |
Abstract
During omalizumab treatment, a high percentage of asthmatics obtain a good or partial control of asthma. Comorbidities are associated with the lack of asthma control and persistence of exacerbations.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Federica Novelli, Manuela Latorre, Letizia Vergura, Maria Filomena Caiaffa, Gianna Camiciottoli, Gabriella Guarnieri, Andrea Matucci, Luigi Macchia, Andrea Vianello, Alessandra Vultaggio, Alessandro Celi, Mario Cazzola, Pierluigi Paggiaro,